TKPHF — TAKEDA PHARMACEUTICAL CO LTD

—
NYSE · Health Care · Pharmaceuticals · CIK 1395064 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
2027-01-28

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 1,187,097,000,000 795,004,000,000 205,322,000,000 192,429,000,000 15,271,498,000,000 418,533,000,000 7,854,322,000,000
Jun 2026 1,219,900,000,000 813,224,000,000 201,417,000,000 113,197,000,000 15,663,271,000,000 460,982,000,000 8,104,395,000,000
Mar 2026 1,094,541,000,000 688,837,000,000 42,068,000,000 -368,471,000,000 15,511,506,000,000 595,054,000,000 8,080,857,000,000
Dec 2025 1,191,698,000,000 790,550,000,000 168,822,000,000 103,640,000,000 15,408,774,000,000 654,937,000,000 7,764,684,000,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$879,671,000,000
Investing CF
$-396,589,000,000
Financing CF
$-761,309,000,000
CapEx
$-445,724,000,000
Dividends Paid
$-315,684,000,000
Buybacks
$-1,007,000,000
EPS Diluted TTM
$148.77
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$859,247,000,000
Inventory
$1,441,087,000,000
Receivables
$910,245,000,000
ST Investments
$35,868,000,000
EBIT TTM
$82,580,000,000
Pretax Income TTM
$-2,471,000,000
Interest Exp TTM
$85,051,000,000
Analysts
—

Yahoo Snapshot (yfinance, live)

Total Revenue
$4,618,934,812,672
EBITDA
$1,249,335,967,744
Free Cash Flow
$541,443,883,008
Enterprise Value
$5,133,704,888,320
Total Cash
$460,981,993,472
Total Debt
$5,536,499,105,792
Shares Out
1,596,751,439
Trailing EPS
$-0.68
Book Value
$31.13
ROE
-2.3%
ROA
2.7%
Div Yield
3.58%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Mar 2026 4,505,720,000,000 464,451,000,000 -152,390,000,000 15,511,506,000,000 8,080,857,000,000 7,429,441,000,000 1,041,431,000,000
Mar 2025 4,581,551,000,000 466,370,000,000 107,928,000,000 14,248,344,000,000 7,312,365,000,000 6,935,084,000,000 1,057,182,000,000
Mar 2024 4,263,762,000,000 309,901,000,000 144,067,000,000 15,108,792,000,000 7,834,787,000,000 7,273,264,000,000 716,344,000,000
Mar 2023 4,027,478,000,000 587,812,000,000 317,017,000,000 13,957,750,000,000 7,603,079,000,000 6,354,122,000,000 977,156,000,000

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.81

Peers — same industry

TickerNameMarket CapLastDaily %
LLY ELI LILLY & Co $1.26T $1415.55 —
JNJ JOHNSON & JOHNSON $670.92B $278.70 —
ABBV AbbVie Inc. $517.59B $292.82 —
MRK Merck & Co., Inc. $353.44B $143.37 —
NVS NOVARTIS AG $302.46B $159.13 —

News headlines (Yahoo Finance, 1h cache)

Novavax Eyes New Partnerships as Sanofi Advances COVID-Flu Vaccine Trial
2026-11-17 21:12 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Start Week Sharply Lower in Monday Trading
2026-11-16 15:48 · Yahoo
Iambic Provides Business Updates and Third Quarter 2026 Financial Results
2026-11-16 13:00 · Yahoo
Asian Equities Traded in the US as American Depositary Receipts Drop Sharply in Thursday Trading
2026-11-12 15:44 · Yahoo
Takeda Launches ORZEYFUL™ (oveporexton), the First and Only Medicine of Its Kind for Narcolepsy Type 1 Now Available in the United States
2026-11-12 12:35 · Yahoo
Ginkgo Bioworks Holdings Inc (DNA) Q3 2026 Earnings Call Highlights: Cost Cuts, First Big ...
2026-11-12 05:05 · Yahoo
ADMA Surges 20.9% Post Q3 Earnings: Buy, Sell or Hold the Stock?
2026-11-11 16:41 · Yahoo
Raised Guidance Could Change The Case For Schrödinger Stock (SDGR)
2026-11-07 20:12 · Yahoo
HRMY Q3 Earnings Miss Estimates on Higher Costs Despite Wakix Growth
2026-11-05 18:04 · Yahoo
DNLI Up 7.8% Post Q3 Earnings: Should You Buy, Sell or Hold the Stock?
2026-11-05 18:01 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.